Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants
Indrani Das Jana, Kawkab Kanjo, Subhanita Roy, Munmun Bhasin, Shatarupa Bhattacharya, Indranath Banerjee, Subhasis Jana, Arjun Chatterjee, Alok Chakraborty, Suman Kumar Chakraborty, Budhaditya Mukherjee, Raghavan Varadarajan, Arindam Mondal
This study analyzes sera from Indian breakthrough infection patients vaccinated with ChAdOx, identifying broad neutralizing activity against SARS-CoV-2 variants, primarily targeting a conserved cryptic class 5 epitope.
Journal of Virology · Mar 26, 2025Peer-reviewedMolecular Biology